RecruitingNCT06698666
Rosuvastatin added to sertraline for adults with depression
About this title
Read the official source — NCT06698666Medication studyAges 20–45Egypt
Understand this study
Who could participate?
Listed age limits: 20 years to 45 years.
- Listed locations
- CairoSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: October 1, 2022
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 145
- Sponsor
- Ain Shams University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- Egypt
- Age range
- From 20 Years to 45 Years
- Official registry ID
- NCT06698666
- Official title
Show the full official title
The Efficacy of Statins in Management of Major Depression Disorder (MDD) Among Adult Patients Attending the Outpatient Clinics of El Demerdash Hospital.
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Cairo
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Ain Shams University, a university.
Does this study involve medication?
Yes. The study involves medication, including Rosuvastatin 10 mg tablet. and Sertraline Pill.
Who can participate?
Listed age limits: 20 years to 45 years.
Is this study still recruiting?
The registry lists this study as recruiting.
